1 completed, 1 terminated, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Axillary Lymph Node Biopsy: new trials by email Literature Review of Axillary Lymph Node Biopsy trials Research Report on Axillary Lymph Node Biopsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer Indocyanine Green Solution, Technetium Tc-99m Sulfur Colloid, Lymphoscintigraphy - Stage I Breast Cancer, Stage II Breast Cancer | Not applicable | Completed | Case Comprehensive Cancer Center | 102 | 2015-02-17 | 2022-06-30 |
| Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients. technetium Tc 99m sulfur colloid, methylene blue, indocyanine green solution - Lymphedema, Recurrent Breast Cancer | Phase 2 | Terminated | University of Southern California | 4 | 2010-12-01 | 2014-08-01 |
| Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer riluzole, polymorphism analysis, axillary lymph node biopsy - Breast Cancer | Phase 1 | Withdrawn | Barbara Ann Karmanos Cancer Institute | 2009-05-01 | 2013-04-29 |
Breast Neoplasms (3) · Lymphedema (1)
Barbara Ann Karmanos Cancer Institute (1) · Case Comprehensive Cancer Center (1) · University of Southern California (1)
United States (2)
David H. Gorski, MD, PhD, FACSw (1) · Dennis Holmes (1) · Stephen Grobmyer, MD (1)
P30CA022453 (1)